![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 26, 2014 4:32:46 AM
Mirror is the same Myocell trial only this time being delivered via the BioHeart MyoCath. Mirror the the phase 3 of Marvel... (Someone correct me if I'm wrong)
REGEN is Myocell SDF-1. It was never started because it isn't intended to yet. Approval for trials was attained but it is a gene modified version of Myocell. In other words, second generation (new and improved). Those trials will probably commence IMO after full enrollment, full funding, and completion of Mirror phase 3.
BioHearts main focus right now is the Mirror trial using BioHearts own developed catheter, MyoCath. Once they can get full enrollment their task is to get Mirror phase 3 to compliment Marvel Phase 2/3 results. Hence the name "Mirror" (again, someone correct me if I'm wrong)
FEATURED Element79 Gold Corp Provides Update on Nevada Portfolio • Aug 23, 2024 8:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM